Randomized trial investigates crystalline composition of zirconia, suggesting pathways for improved durability in dental applications.
Yttria-stabilized zirconia (YSZ) has become indispensable in restorative dentistry; however, the influence of yttria content on its crystalline phases and fine structure remains incompletely understood. This study investigated how variations in yttria content (3–8 mol%) and low-temperature degradation (LTD) influence the crystalline phase composition and local atomic structures of dental zirconia using synchrotron-based X-ray diffraction (XRD) and X-ray absorption fine structure (XAFS) spectroscopy. Forty-two sintered disc-shaped specimens were prepared from zirconia powders stabilized with 3–8 mol% yttria (3–8YSZ). Half of the specimens were polished, while the other half underwent autoclaving to induce LTD. Synchrotron XRD showed that 3–5YSZ contained 2 tetragonal ( t and t′ ) phases, while 8YSZ contained a cubic ( c ) phase. The t -phase fraction decreased markedly with increasing yttria content, from 83.1 mass% in 3YSZ to 25.3 mass% in 5YSZ. LTD induced monoclinic ( m ) and rhombohedral ( r ) phases in 3YSZ and 4YSZ but not in 5YSZ, indicating improved LTD resistance at higher yttria contents. XAFS showed that the dual-peak white-line profile of zirconia specimens varied with yttria content, reflecting the t -to- t′ phase transition, and transformed into a single broadened peak after LTD, consistent with structural disorder induced by phase transformation. Fine structural analysis revealed 2 main coordination shells, Zr–O and Zr–Zr. In the Zr–Zr shell, the Debye–Waller factors changed systematically with yttria content, reflecting structural disorder associated with oxygen vacancies. In conclusion, a combined synchrotron XRD and XAFS approach elucidated the phase composition and atomic-scale structural disorder in dental zirconia across different yttria contents. These insights provide a foundation for the rational design of next-generation translucent dental zirconia, in which crystalline phase composition and local atomic disorder are deliberately tailored to achieve durable clinical performance.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: